NovaBridge Biosciences Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

235.92M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	632.00K	2.18M	-
Dec 31, 2022	-1.55M	-15.40M	-
Dec 31, 2021	13.85M	-222.30M	-94.14%
Dec 31, 2020	236.15M	231.84M	5,381.19%
Dec 31, 2019	4.31M	2.53M	142.56%
Dec 31, 2017	1.78M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Fulcrum Therapeutics	80.00M
Cellectis	75.11M
Invivyd	55.87M
Atrium Therapeutics	36.68M
Orchestra BioMed Holdings	32.72M
Sol-Gel Technologies	18.47M
ProQR Therapeutics	15.73M
AC Immune	4.62M

Revenue Rankings

NBP News

7 days ago - NovaBridge CEO Xi-Yong Fu to step down, Srishti Gupta to succeed - TheFly
7 days ago - NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer - GlobeNewsWire
20 days ago - NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer - GlobeNewsWire
4 weeks ago - NovaBridge Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
5 weeks ago - NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
6 weeks ago - NovaBridge Biosciences Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
7 weeks ago - NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference - GlobeNewsWire
2 months ago - NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value - GlobeNewsWire

More News